# Total Body Irradiation/Fludarabine Based Ablative Haploidentical Transplant for Hematologic Diseases

> **NCT01336712** · PHASE2 · COMPLETED · sponsor: **Northside Hospital, Inc.** · enrollment: 30 (actual)

## Conditions studied

- Chronic Leukemia
- Acute Leukemia
- Hodgkin's Disease
- Non-Hodgkin's Lymphoma
- Myelodysplastic Syndrome

## Interventions

- **PROCEDURE:** Peripheral Blood Stem Cell Transplant

## Key facts

- **NCT ID:** NCT01336712
- **Lead sponsor:** Northside Hospital, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2014-12
- **Final completion:** 2015-07
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2016-01-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01336712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01336712, "Total Body Irradiation/Fludarabine Based Ablative Haploidentical Transplant for Hematologic Diseases". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01336712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*